Last reviewed · How we verify
aspirin, clopidogrel, cilostazol
aspirin, clopidogrel, cilostazol is a Small molecule drug developed by Shenyang Northern Hospital. It is currently FDA-approved.
Aspirin, clopidogrel, and cilostazol are marketed drugs under Shenyang Northern Hospital, with a key composition patent expiring in 2028. The primary strength of these drugs lies in their established market presence and broad therapeutic applications. The primary risk is the potential increase in generic competition following the 2028 patent expiry.
At a glance
| Generic name | aspirin, clopidogrel, cilostazol |
|---|---|
| Sponsor | Shenyang Northern Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis (PHASE4)
- Randomized Clinical Trial of Endovascular Recanalization for Symptomatic Non-Acute Intracranial Artery Occlusion（REPAIR） (NA)
- Prevention of Stroke Recurrence and Disease Progression in Cerebral Small Vessel Disease With Cilostazol (PHASE4)
- Combining Aspirin With Ticagrelor or Cilostazol in Large-vessel Minor Stroke or TIA (PHASE3)
- Combining Aspirin With Ticagrelor or Clopidogrel in Large-vessel Minor Stroke or TIA (PHASE3)
- Pioneering Advancements in Cardiocerebrovascular Interactions in the Asia pacFIC - Patent Foramen Ovale Study
- Antiplatelet Therapy and Endothelial-stabilizing Agents in Cerebral Small Vessel Diseases
- Antiplatelet Secondary Prevention International Randomised Trial After INtracerebral HaemorrhaGe (ASPIRING)-Pilot Phase (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- aspirin, clopidogrel, cilostazol CI brief — competitive landscape report
- aspirin, clopidogrel, cilostazol updates RSS · CI watch RSS
- Shenyang Northern Hospital portfolio CI
Frequently asked questions about aspirin, clopidogrel, cilostazol
What is aspirin, clopidogrel, cilostazol?
Who makes aspirin, clopidogrel, cilostazol?
What development phase is aspirin, clopidogrel, cilostazol in?
Related
- Manufacturer: Shenyang Northern Hospital — full pipeline